A dual CK1δ/ε inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PF-5006739

Item No. 46620

Technical Information
Formal Name
4-[4-(4-fluorophenyl)-1-[1-(3-isoxazolylmethyl)-4-piperidinyl]-1H-imidazol-5-yl]-2-pyrimidinamine
CAS Number
1293395-67-1
Molecular Formula
C22H22FN7O
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥ 10 mg/ml
SMILES
FC1=CC=C(C(N=C2)=C(C3=CC=NC(N)=N3)N2C4CCN(CC4)CC5=NOC=C5)C=C1
InChi Code
InChI=1S/C22H22FN7O/c23-16-3-1-15(2-4-16)20-21(19-5-9-25-22(24)27-19)30(14-26-20)18-6-10-29(11-7-18)13-17-8-12-31-28-17/h1-5,8-9,12,14,18H,6-7,10-11,13H2,(H2,24,25,27)
InChi Key
XPWHRQHBPRSUAW-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    PF-5006739 is a dual inhibitor of casein kinase 1δ (CK1δ) and CK1ε (IC50s = 3.9 and 17 nM, respectively).1 It is selective for CK1δ/ε over a panel of 57 kinases at 1 µM but does inhibit JNK2 and misshapen-like kinase 1 (MINK1), also known as ZC3 (IC50s = 6.1 and 1.5 µM, respectively). PF-5006739 (10 mg/kg) induces circadian phase delays in mice and cynomolgus monkeys. It prevents reinstatement of fentanyl-seeking behavior in a rat model of drug relapse. PF-5006739 also improves glucose tolerance but does not affect body weight in high-fat diet-induced obese mice and ob/ob mice.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wager, T.T., Chandrasekaran, R.Y., Bradley, J., et al. Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior. ACS Chem. Neurosci. 5(12), 1253-1265 (2014).

    2. Cunningham, P.S., Ahern, S.A., Smith, L.C., et al. Targeting of the circadian clock via CK1δ/ε to improve glucose homeostasis in obesity. Sci. Rep. 6, 29983 (2016).